Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Clifford Stocks
|
| gptkbp:collaboratedWith |
gptkb:MD_Anderson_Cancer_Center
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
immuno-oncology
antibody therapeutics |
| gptkbp:foundedYear |
2015
|
| gptkbp:founder |
Clifford Stocks
James B. Allison Theresa LaVallee |
| gptkbp:headquartersLocation |
gptkb:Houston,_Texas
|
| https://www.w3.org/2000/01/rdf-schema#label |
OncoResponse
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:investor |
gptkb:Redmile_Group
gptkb:8VC gptkb:Canaan_Partners gptkb:ARCH_Venture_Partners gptkb:RiverVest_Venture_Partners |
| gptkbp:platform |
antibody discovery from elite cancer responders
|
| gptkbp:products |
monoclonal antibodies for cancer treatment
|
| gptkbp:website |
https://oncoresponse.com/
|
| gptkbp:bfsParent |
gptkb:Two_Bear_Capital
|
| gptkbp:bfsLayer |
8
|